Lisata Therapeutics (LSTA) Payables (2016 - 2025)
Historic Payables for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $619000.0.
- Lisata Therapeutics' Payables rose 1133.09% to $619000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $619000.0, marking a year-over-year increase of 1133.09%. This contributed to the annual value of $1.3 million for FY2024, which is 4696.41% down from last year.
- As of Q3 2025, Lisata Therapeutics' Payables stood at $619000.0, which was up 1133.09% from $782000.0 recorded in Q2 2025.
- In the past 5 years, Lisata Therapeutics' Payables ranged from a high of $2.4 million in Q4 2023 and a low of $556000.0 during Q3 2024
- Moreover, its 3-year median value for Payables was $782000.0 (2025), whereas its average is $1.1 million.
- Its Payables has fluctuated over the past 5 years, first crashed by 5762.2% in 2024, then skyrocketed by 1133.09% in 2025.
- Over the past 3 years, Lisata Therapeutics' Payables (Quarter) stood at $2.4 million in 2023, then crashed by 46.96% to $1.3 million in 2024, then tumbled by 51.79% to $619000.0 in 2025.
- Its Payables was $619000.0 in Q3 2025, compared to $782000.0 in Q2 2025 and $602000.0 in Q1 2025.